India’s incentives for domestic API production could cut supply risk: Fitch
NEW DELHI: The Indian government’s recent incentives to boost domestic manufacturing of active pharmaceutical ingredients (APIs) and key starting materials (KSMs) can improve backward integration over the next few years and curtail supply-chain disruption risk for Indian drug makers, Fitch Ratings said on Monday. The incentives address core issues of pricing competitiveness and funding, and […]